guanethidine has been researched along with Atrophy in 1 studies
Guanethidine: An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues.
guanethidine : A member of the class of guanidines in which one of the hydrogens of the amino group has been replaced by a 2-azocan-1-ylethyl group.
guanethidine sulfate : A organic sulfate salt composed of two molecules of guanethidine and one of sulfuric acid.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonnet, M | 1 |
| Lemarchands, H | 1 |
| Martin, J | 1 |
1 other study available for guanethidine and Atrophy
| Article | Year |
|---|---|
[Prevention and treatment of the "irreducible mydriasis--progressive atrophy of the iris" syndrome following perforating keratoplasty for keratoconus].
Topics: Acetylcholine; Anesthetics, Local; Atrophy; Atropine; Eye Diseases; Eye Injuries; Guanethidine; Huma | 1969 |